Design Therapeutics Balance Sheet (2020-2026) | DSGN

Balance Sheet Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
357.66M298.57M287.31M119.65M42.52M26.50M28.81M27.20M27.94M21.20M29.40M45.70M30.33M22.56M13.67M19.70M15.09M16.86M12.77M12.91M
Short-term Investments (Quarter)
0.10M85.50M83.91M239.72M301.72M303.89M286.58M275.89M263.00M260.60M241.29M215.32M223.75M222.91M216.01M196.57M190.88M202.99M210.05M194.49M
Cash & Current Investments (Quarter)
357.77M384.06M371.22M359.38M344.23M330.39M315.39M303.09M290.94M281.80M270.69M261.02M254.07M245.48M229.67M216.28M205.97M219.84M222.82M207.40M
Prepaid Assets (Quarter)
1.42M1.26M0.11M2.35M4.25M4.73M2.57M1.96M3.60M2.79M3.20M2.43M3.17M1.30M3.97M2.17M1.68M3.94M2.40M4.62M
Current Assets (Quarter)
395.29M385.44M373.87M361.72M348.49M335.12M318.94M306.05M294.54M284.58M273.89M264.84M257.24M248.04M233.64M219.79M209.03M223.78M227.05M212.01M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
1.32M1.51M1.45M1.80M1.84M1.95M1.91M1.86M1.78M1.69M1.72M1.73M1.56M1.41M1.38M1.26M1.10M0.98M0.82M0.69M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)
0.47M0.47M0.46M0.45M0.44M0.44M0.43M0.43M0.43M0.43M0.43M0.43M
Non-Current Assets (Quarter)
5.06M5.12M4.93M6.21M6.08M6.02M5.80M5.58M5.33M5.06M4.91M4.74M4.39M4.05M3.83M3.09M2.74M2.42M3.39M3.12M
Assets (Quarter)
400.35M390.56M378.80M367.93M354.57M341.14M324.74M311.63M299.87M289.64M278.79M269.58M261.63M252.09M237.47M222.89M211.77M226.20M230.44M215.13M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
2.22M1.62M1.90M2.07M2.62M3.02M2.74M1.92M2.21M1.94M1.37M1.30M1.47M2.19M3.18M1.01M1.91M2.31M2.28M3.14M
Payables (Quarter)
2.22M1.62M1.90M2.07M2.62M3.02M2.74M1.92M2.21M1.94M1.37M1.30M1.47M2.19M3.18M1.01M1.91M2.31M2.28M3.14M
Accumulated Expenses (Quarter)
3.29M3.66M3.58M5.32M7.79M7.75M6.30M10.21M10.18M7.68M5.72M5.10M5.96M6.28M5.06M7.73M9.26M10.74M7.91M8.10M
Other Accumulated Expenses (Quarter)
Total Current Liabilities (Quarter)
5.50M5.28M5.48M7.39M10.41M10.78M9.05M12.13M12.39M9.62M7.09M6.39M7.43M8.46M8.24M8.75M11.17M13.05M10.19M11.24M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
3.27M3.14M3.01M3.38M3.22M3.05M2.88M2.70M2.52M2.33M2.14M1.95M1.74M1.53M1.32M1.10M0.88M0.65M2.20M2.03M
Other Non-Current Liabilities (Quarter)
0.01M
Total Non-Current Liabilities (Quarter)
8.78M
Total Liabilities (Quarter)
8.79M8.43M8.49M10.77M13.63M13.83M11.93M14.84M14.91M11.96M9.24M8.34M9.18M10.00M9.56M9.85M12.05M13.70M12.39M13.27M
Shareholder's Equity
Common Equity (Quarter)
391.56M382.13M370.31M357.16M340.94M327.31M312.82M296.80M284.96M277.69M269.56M261.24M252.45M242.10M227.92M213.04M199.72M212.50M218.05M201.86M
Liabilities and Shareholders Equity (Quarter)
400.35M390.56M378.80M367.93M354.57M341.14M324.74M311.63M299.87M289.64M278.79M269.58M261.63M252.09M237.47M222.89M211.77M226.20M230.44M215.13M
Retained Earnings (Quarter)
-0.00M-0.24M-1.32M-2.31M-3.86M-3.36M-130.10M-150.00M-165.80M0.06M-0.17M-200.50M-213.56M-227.21M-244.90M-264.01M-281.00M0.40M-314.64M-334.81M
Treasury Shares (Quarter)